ADMA BIOLOGICS, INC. (ADMA): auditor change — ADMA Biologics engages KPMG as new auditor effective after Q3 2024 10-Q filing

ADMA BIOLOGICS, INC.

KPMG appointed as independent registered public accounting firm on October 31, 2024, effective upon filing of Q3 2024 10-Q.
No consultations or disagreements with KPMG during prior fiscal years 2022-2023 and interim period through October 31, 2024.
KPMG will audit the consolidated financial statements for FY 2024, expected to be filed by March 3, 2025.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ADMA BIOLOGICS, INC. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

On October 31, 2024, ADMA Biologics, Inc. (the “Company”) and KPMG LLP (“KPMG”) executed an agreement pursuant to which KPMG will initiate its engagement and serve as the Company’s new independent registered public accounting firm effective upon the filing of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024.

View on SEC.gov

Browse all auditor changes →

ADMA BIOLOGICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-24-044808

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.